Optegra, UK’s leading eye health care group raises global awareness during World Glaucoma Week March 12-18, 2017
Optegra Eye Health Care Group, specialist provider of ophthalmic services in the UK takes the lead to expand global awareness of glaucoma during World Glaucoma Week March 12-18, 2017.
March 13, 2017 ( datsyn.com) – London, United Kingdom – Often known as the silent thief of sight, Glaucoma is a degenerative eye condition that is usually caused by a build up of intra-ocular pressure (IOP) inside the eye. This increased pressure can damage the optic nerve which transmits images to the brain. If left untreated, the continual damage to the optic nerve can cause permanent loss of vision.
Glaucoma although a gradual disease showing no symptoms is more prevalent with age. The most common type of Glaucoma referred to as primary open angle glaucoma affects up to 2 in 100 people over 40 and around 10 in 100 people over 75.
Although Glaucoma is not preventable, significant vision loss or blindness can be prevented if the disease is recognised in the early stages by getting regular comprehensive eye exams, taking prescribed eye drops, knowing family history of Glaucoma and wearing eye protection.
With the advancement of science, patients can now also opt for Glaucoma Monitoring Service that identifies and captures any potential risks or developments over a 12 month period. Suitable for anyone who has or is at risk of developing glaucoma, the Glaucoma Monitoring Service provides patients the opportunity to be assessed by an Optometrist and a Consultant Ophthalmic Surgeon through a series of comprehensive tests. This service is currently available at a number of Optegra Eye Hospitals
To learn more about Glaucoma, the leading cause of irreversible blindness in the world, its causes and to find out if you’re at risk visit www.optegra.com or call 0808 178 2815 Mon-Fri 8am-8pm, Sat 9am-4pm.
Optegra Eye Health Care is a specialist provider of ophthalmic services in the UK, China, Czech Republic, Poland and Germany. Optegra operates 23 eye hospitals and clinics and brings together leading edge research and medical expertise, state-of-the-art surgical equipment and top ophthalmic surgeons renowned for their areas of expertise to offer excellent clinical outcomes in laser vision correction, glaucoma, refractive lens exchange (Clarivu™), cataract removal, AMD, vitreoretinal and oculoplastics procedures all carried out in five-star patient facilities.
Optegra Eye Health Care operates seven dedicated eye hospitals based in Birmingham, Central London, Hampshire, Manchester, North London, Surrey and Yorkshire. For more information please visit www.optegra.com